BCL6 and lymphoma: As a highly conserved transcript suppressor, BCL6 was reported to act as proto-oncogene by affecting cancer hallmark pathways including proliferation, DNA repair, anti-apoptosis, and enable cancer cells to adapt to stress in both lymphoma and solid tumor.